March 25, 2021—Boston Scientific Corporation announced that data from the TARGET study of the TheraSphere Y-90 glass microspheres were presented during a late-breaking clinical trial session at the Society of Interventional Radiology (SIR) annual…
Category: News
Sirtex Medical Receives FDA Approval to Conduct DOORwaY90 Study of SIR-Spheres in Unresectable HCC
March 22, 2021––Sirtex Medical announced full FDA approval of the DOORwaY90 study, which is evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using the company’s SIR-Spheres yttrium-90 (Y-90) resin micr…